Systemic Lupus Erythematosus News and Research

RSS
Systemic lupus erythematosus (SLE) is the form of the disease that most people are referring to when they say "lupus." The word "systemic" means the disease can affect many parts of the body. The symptoms of SLE may be mild or serious. Although SLE usually first affects people between the ages of 15 and 45 years, it can occur in childhood or later in life as well.
AI could improve accuracy and speed of lupus nephritis diagnosis

AI could improve accuracy and speed of lupus nephritis diagnosis

Is DNA methylation the missing link in diagnosing and treating psoriasis and psoriatic arthritis?

Is DNA methylation the missing link in diagnosing and treating psoriasis and psoriatic arthritis?

Scientists reclassify 200 rare immune system disorders using network-based approach

Scientists reclassify 200 rare immune system disorders using network-based approach

Study discovers method to classify febrile illness with a single blood sample

Study discovers method to classify febrile illness with a single blood sample

Small molecule inhibitor of the NLRP3 inflammasome for treating autoinflammatory diseases

Small molecule inhibitor of the NLRP3 inflammasome for treating autoinflammatory diseases

COVID-19 associated with increased risk of developing various autoimmune diseases and risk could be attenuated by vaccination

COVID-19 associated with increased risk of developing various autoimmune diseases and risk could be attenuated by vaccination

Powerful imaging mass cytometry could revolutionize the diagnosis of lupus nephritis

Powerful imaging mass cytometry could revolutionize the diagnosis of lupus nephritis

The role of self-extracellular nucleic acids in neuroinflammation

The role of self-extracellular nucleic acids in neuroinflammation

EULAR releases new recommendations for non-pharmacological management of SLE and SSc

EULAR releases new recommendations for non-pharmacological management of SLE and SSc

Study shows that anti-PTM antibodies are often present in autoimmune mediated liver disease

Study shows that anti-PTM antibodies are often present in autoimmune mediated liver disease

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

2023 recipients of the Diversity in Lupus Research Awards announced

2023 recipients of the Diversity in Lupus Research Awards announced

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Measurable upticks in gut bacteria blooms tied to lupus flare-ups

Measurable upticks in gut bacteria blooms tied to lupus flare-ups

Unlocking the secret to lifelong health: the power of optimal immune resilience

Unlocking the secret to lifelong health: the power of optimal immune resilience

Estimate of treatment effect modification by comorbidity using participant data

Estimate of treatment effect modification by comorbidity using participant data

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Study finds improved survival in patients with SLE-associated PAH

Study finds improved survival in patients with SLE-associated PAH

Long-term side effects of modern treatment for rheumatoid arthritis

Long-term side effects of modern treatment for rheumatoid arthritis

Rheumatic and musculoskeletal diseases increase the risk of lethal comorbidities

Rheumatic and musculoskeletal diseases increase the risk of lethal comorbidities